An Open-Label Pilot Study of Qualia Senolytic Supplementation for the Attenuation of Systemic Inflammatory Cytokines
NANot yet recruitingINTERVENTIONAL
Enrollment
40
Participants
Timeline
Start Date
May 12, 2025
Primary Completion Date
May 18, 2025
Study Completion Date
May 18, 2025
Conditions
Inflammation
Interventions
DIETARY_SUPPLEMENT
Qualia Senolytic
Qualia Senolytic manufactured by Qualia Life Science
Trial Locations (1)
92011
Qualia Life Sciences, Carlsbad
All Listed Sponsors
lead
Qualia Life Sciences
INDUSTRY
NCT06953518 - An Open-Label Pilot Study of Qualia Senolytic Supplementation for the Attenuation of Systemic Inflammatory Cytokines | Biotech Hunter | Biotech Hunter